Advaxis named Al Blunt, M.D., as its vice president of medical. Dr. Blunt joins Advaxis from Covance where he was executive medical director for oncology. Dr. Blunt joined Covance in 1998, holding several positions increasing in responsibility over nearly 20 years.
Allegro Ophthalmics appointed Melvin Sarayba, MD, vice president of clinical affairs. Dr. Sarayba is responsible for Allegro’s U.S. and international clinical program for Luminate.
Richard L. Wang is now chief executive officer of Fosun Kite Biotechnology. Dr. Wang has extensive experience in the biopharmaceutical industry in the U.S. and China, including leadership roles at Procter & Gamble, Bristol-Myers Squibb, AstraZeneca and GlaxoSmithKline. He most recently served as chief operating officer of Cellular Biomedicine Group.